Citius Pharmaceuticals, Inc.: Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma : vimarsana.com

Citius Pharmaceuticals, Inc.: Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma

Citius Pharmaceuticals, Inc.: Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Phoenix , Arizona , California , Chicago , Illinois , University Of Minnesota , Minnesota , Orange County , Los Angeles , Ilanit Allen , Myron Czuczman , Matthew Mei , Veronika Bachanova , Greg Salsburg , Dennis Riedl , Citius Pharma , Kite Pharma Inc , University Of Minnesota Masonic Cancer Center , Company Nasdaq , Securities Exchange , Translational Genomics Research Institute , Citius Pharmaceuticals Inc , Novartis Pharmaceuticals Corporation , Prnewswire Citius Pharmaceuticals Inc , Cancer Center , Juno Therapeutics Inc , National Cancer Institute , Bristol Myers Squibb , Masonic Cancer Center , Department Of Medicine , Gilead Sciences Inc , Division Of Hematology , Exchange Commission , Minnesota Masonic Cancer Center , Cancer Institute , Biologics License Application , Chief Medical Officer , Minnesota Masonic Cancer , Comprehensive Cancer Center , Southern California , Citius Pharmaceuticals , Citius Oncology , Securities Act , Securities Exchange Act , Annual Report , Novartis Pharmaceuticals , Kite Pharma , Gilead Sciences , Juno Therapeutics ,